induced pluripotent stem cell-derived glial-restricted progenitor cell therapy (MAGiQ Therapeutics/Q Therapeutics)

N/A

Report date: 2025/03/20 15:25:33

Base Information

Drug Nameinduced pluripotent stem cell-derived glial-restricted progenitor cell therapy (MAGiQ Therapeutics/Q Therapeutics)
Drug Alias NameiPSC-derived glial-restricted progenitor cell therapy (Q Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapy
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQ Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMAGiQ Therapeutics IncQ Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A